Polyrotaxanes (PRXs) are a class of supramolecular threaded macromolecules, in which cyclic molecules are threaded onto the main-or side-chain of polymers. To date, various studies have been conducted on the synthesis of PRXs, and various combinations of cyclic molecules and polymers that can form a PRX have been discovered. Among these combination, PRXs composed of cyclodextrins (CDs) and a linear polymer have attracted much attention and have been investigated by many researchers. Because of the non-covalently associated characteristic of PRXs, these supermolecules exhibit unique properties, such as the dynamic motion of the threaded cyclic molecules along a polymer axle and complete dissociation of the supramolecular structure, that are never observed in other synthetic polymers. These inherent properties of PRXs are of interest in the design of novel biomaterials, such as hydrogels, scaffolds in tissue engineering, drug delivery carriers, and polymer-drug conjugates. Thus, various studies have been conducted to utilize PRXs as a framework for biomaterials. In this review, we describe the recent progress in biomaterial application of PRXs such as drug delivery and gene delivery.
Introduction
The biomedical application of polymeric materials is recognized as an emerging topic of interest. 1, 2 The molecular architecture of polymers is one of the main factors affecting the properties of polymeric biomaterials. Various polymers including synthetic polymers, biopolymers, hyper-branched polymers, and dendritic polymers have been used in tissue engineering, regenerative medicine, and drug delivery systems. Polyrotaxanes (PRXs) are a class of supramolecular threaded macromolecules, in which cyclic molecules are threaded onto the main-or side-chain of polymers. [3] [4] [5] [6] [7] [8] Among these supermolecules, PRXs composed of many cyclic molecules threaded onto a polymer axle have extensively been investigated (Figure 1) . The synthesis of PRXs composed of dissociation of the entire supramolecular structure; in contrast, conventional biodegradable polymers degrade incompletely via hydrolysis. These unique characteristics of PRXs that are derived from their supramolecular structures are of special interest for designing novel biomaterials. In this review, we describe the recent progress of PRXs and pseudopolyrotaxanes as supramolecular biomaterials, with a particular focus on the CD-based PRXs.
Polyrotaxane hydrogels

Chemically cross-linked polyrotaxane hydrogels
Biocompatible and biodegradable polymeric materials have been widely used as implantable materials to modulate the release of drugs and as scaffolds for cell implantation. 36 In particular, aliphatic polyesters, such as poly(L-lactide) and poly(lactide-co-glycolide), are utilized as biodegradable materials. 35 However, the hydrolytic degradation of polyesters under in vivo conditions is not ideal, because the crystalline oligomers and unhydrolyzed polymers remain at implantation sites for a long time and thus elicit a chronic inflammatory response. Chemically cross-linked hydrogels have attracted much interest as alternative implantable biomaterials. 38 These chemically cross-linked hydrogels can incorporate various therapeutic payloads, such as macromolecular drugs and proteins, within the gel network. Additionally, biocompatible hydrogels can be transplanted into the body and act as an implantable drug reservoir under in vivo conditions.
To date, various methods for constructing chemically cross-linked hydrogels have been developed, such as the polymerization of monomers and appropriate cross-linkers and the chemical cross-linking of hydrophilic polymers. 38, 39 Our group has reported biodegradable supramolecular hydrogels using hydrolyzable PEG/α-CD-based PRX-bearing ester linkages as a framework for a gel network. 40 Because the hydrolysis of any of the ester groups at either of the two terminals of PEG triggers the complete dissociation of a PEG/α-CD complex, these PRX-based hydrogels are anticipated to perfectly and Another method for preparing hydrogels is the physical gelation caused by non-covalent self-assembly, such as the assembly caused by hydrophobic interactions, hydrogen bonding, and electrostatic interactions. 39 During studies on the inclusion complexation between CD and linear polymers, Harada and co-workers first reported the unique sol-gel transition behavior of inclusion complexes. 47 In the formation of an inclusion complex between PEG and α-CD in aqueous media, the complexes exhibited physical gelation. This gelation is thought to occur with the intramolecular hydrogen bonding between α-CDs on the pseudopolyrotaxanes ( Figure 2B ). The time of gelation is dependent on the concentration of both PEG and α-CD in aqueous media and the molecular weight of PEG. In particular, when the concentration of PEG and α-CD is sufficiently high, the mixture exhibits rapid gelation. Because of the lack of a covalent cross-linking point and the rapid gelation of the pseudopolyrotaxane hydrogels, these molecules could be applied as injectable hydrogels.
These PEG/CD hydrogels allow physical entrapment of bioactive molecules, such as proteins. 48 For example, Arima and co-workers have demonstrated the preparation of insulin-loaded PEG/γ-CD hydrogels, in which the three-dimensional structure of insulin is maintained. 49 Li and co-workers have studied the release kinetics of fluorescein isothiocyanate-labeled dextran (FITC-dextran) from PEG/α-CD hydrogels. 50 The release rate decreases as the molecular-weight of PEG increases. This decrease is presumably due to the chain entanglement effect of the high molecular weight PEG. The hydrogels prepared from PEG with a molecular weight of 35,000 or 100,000 exhibit sustained release profiles, and almost all of the FITC-dextran is released from these hydrogels within 120 h.
Although the release kinetics are regulated by varying the molecular weight of PEG, they appear to be relatively fast. Further molecular design of the supramolecular hydrogels is required to achieve long-term drug release under in vivo conditions.
Based on the self-assembly of α-CD-threaded polymers, various supramolecular hydrogel systems have been developed. 48 To achieve long-term drug release from supramolecular hydrogels, Li and co-workers have utilized amphiphilic triblock copolymers,
, as an axle polymer to induce gelation with α-CDs. 51 The cooperation effect of hydrogen bonding between α-CD-threaded PEG segments (PRX segments) and the hydrophobic interaction between PHB segments resulted in the formation of supramolecular hydrogels with a stable macromolecular network. The in vitro release kinetics studies of FITC-Dex from the hydrogel revealed that the PEG-b-PHB-b-PEG/α-CD hydrogels achieved long-term sustained controlled release of macromolecular drugs over 26 days.
Application of the hydrogel as a promising injectable drug delivery system has been suggested.
Similarly, the use of other amphiphilic diblock or triblock copolymers, such as PEG-b-poly(ε-caprolactone), PEG-b-poly(propylene glycol) (PPG)-b-PEG, and PCL-b-PEG-b-PCL, as axle polymers for preparing supramolecular hydrogels with CDs has also been demonstrated.
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Zhang and co-workers have encapsulated lysozymes in supramolecular hydrogels composed of PEG-b-PCL diblock copolymers and α-CDs. 54 The enzymatic activity of the lysozymes encapsulated in the supramolecular PEG-b-PCL/α-CD gel network was maintained for 14 days, whereas the activity of native lysozymes significantly decreased during 7 days of incubation. Accordingly, PRX-based supramolecular hydrogels are thought to be an excellent candidate for protein delivery.
To utilize such an inclusion complex as reversible crosslinks in stimulus-responsive hydrogel systems, our group has developed supramolecular hydrogels using PEG-grafted dextran (PEG-g-Dex) as an axle polymer for α-CDs. 55 α-CDs are threaded onto the PEG-tethered chain of PEG-g-Dex to induce gelation. The gelation time for PEG-g-Dex/α-CD is typically short compared with that of the PEG/α-CD system. In addition, PEG-g-Dex/α-CD hydrogels exhibit a unique temperature-dependent gel-sol transition based on supramolecular assembly and disassembly.
Furthermore, our group has developed stimulus-responsive supramolecular pseudopolyrotaxane hydrogels, whose rheological properties can be modulated in response to pH changes. 56 Herein, poly(ethylenimine) (PEI)-b-PEG-b-PEI triblock copolymers form an inclusion complex with α-or γ-CDs under alkaline pH condition, 57 and the α-CD mobility along the PEI-b-PEG-b-PEI chain both the PEG and PEI segments of the grafted chains at pH 10. In contrast, the networks exhibit a loose nature at pH 4, presumably due to the formation of a partial double-stranded inclusion only on the PEG segments of the grafted chains. Therefore, the macroscopic rheological changes in PEG-PEI-Dex/γ-CD hydrogels result from molecular mechanical actuations of the double-stranded inclusion system in supramolecular networks. This system has a latent possibility for constructing contractile muscle systems.
Physical gelation between cyclodextrins and PEGylated proteins
PEG-modified proteins are currently regarded as essential proteins for pharmaceuticals. 59 PEG modification, often called PEGylation, of a protein provides high solubility in aqueous media, stability in physiological conditions, and a prolonged half-life in the bloodstream. To further expand the utility of the PEGylated protein pharmaceuticals, Uekama and co-workers have developed supramolecular hydrogels between PEGylated insulin and CDs. [60] [61] [62] These researchrs have demonstrated supramolecular gelation between PEGylated insulin and various CDs; α-and γ-CDs formed hydrogels with PEGylated insulin, whereas no gelation was observed with β-CD. The
PEGylated insulin molecules were released from the hydrogels through the dissociation of the PEG/CD inclusion complexes. The release rate could be modulated by the concentration of hydrogels in the medium and the number of PEG chains on the insulin. 61, 62 Additionally, these researchers subcutaneously administered the PEGylated insulin/CD hydrogels to rats. [60] [61] [62] When insulin or PEGylated insulin was subcutaneously administered, the time required to reach the maximum level of insulin in the plasma was determined to be 0.25 or 0.42 h, and the plasma insulin level decreased to the basal level within 2 or 4 h, respectively. In contrast, the PEGylated insulin/CD hydrogels significantly maintained the plasma insulin level, and the insulin level decreased to the basal level after more than 6 h. Additionally, the PEGylated insulin/CD hydrogels exhibited a significantly prolonged reduction in the plasma glucose level comparison with that for insulin and PEGylated insulin. These results indicate that using PRX-based supramolecular hydrogels is a promising strategy to modulate the body disposition and to enhance the therapeutic efficacy of PEGylated proteins.
This supramolecular injectable hydrogel technique can be applied to other PEGylated proteins and to other PEGylated materials. PEGylated lysozyme and PEGylated and α-CD-conjugated poly(amidoamine) dendrimer (generation of dendrimer: G2) have also been observed to form supramolecular hydrogels upon addition of the α-or γ-CDs. 63, 64 In these hydrogels, the supramolecular hydrogel formulations achieve sustained release of the payloads through the dissociation of pseudopolyrotaxanes. Sedlák and co-workers have reported PEG/α-CD hydrogels in which the terminal of the PEG chains is capped with low-molecular-weight drugs (prednisolone) via acid-labile hydrazone linkages. 65 The prednisolone is released from the hydrogels by the cleavage of the hydrazone linkages under the acidic conditions. Accordingly, the supramolecular hydrogel system based on the self-assembly of pseudopolyrotaxanes is a versatile method for delivering various PEGylated materials and drugs.
3. Nanoassemblies of polyrotaxanes 3.1. Self-assembled nanoparticle formation of polyrotaxanes.
Nanoparticle formulations are regarded as a promising modality in the current drug delivery system (DDS). 66, 67 In particular, self-assembled nanoparticles, such as polymeric micelles and liposomes, have attracted much attention as drug carriers. 68, 69 Polymeric micelles are typically constructed from the self-assembly of amphiphilic diblock copolymers composed of a hydrophilic segment and a hydrophobic segment. The hydrophobic segments in the diblock copolymers self-assemble in aqueous solution to form a hydrophobic core that is segregated from the hydrophilic segments that form the surrounding polymer layer. Hydrophobic drugs can be encapsulated in the core of 
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The intermolecular interaction between PRXs has also been used to form self-assembled nanoparticles. A promising method of constructing polymeric micelles through the self-assembly of PRXs involves PRX-containing ABA-type triblock copolymers that comprise a central PRX segment and hydrophilic polymer chains, and various PRX-containing triblock copolymers have been developed ( Figure 3A) . [79] [80] [81] [82] [83] For example, Feng and coworkers have synthesized PRX-based triblock copolymers bearing hydrophilic polymers, such as poly(N-hydroxypropylmethacrylamide) (PHPMA), poly(ethylene glycol) methyl ether methacrylate (PEGMA), and temperature-responsive
PIPAAm. [79] [80] [81] [82] The central PRX segments self-assemble in aqueous solution to form a segregated core of nanoparticles, and the hydrophilic polymer segments form the outermost layer to provide In contrast to these PRX-based polymeric micelles self-assembled from the intermolecular interaction of PRX segments, our group has developed PRX-based triblock copolymers bearing hydrophobic polymer chains to form supramolecular polymeric micelles through the hydrophobic interaction of the polymers ( Figure 3B) . 84, 85 These polymeric micelles display an outermost layer of movable PRX, which is expected to contribute to enhancing the multivalent interaction with receptor proteins if any biological ligands are incorporated into the CDs. 31, 34 The supramolecular flower-like micelles have the appealing property of being able to incorporate hydrophobic drugs within the core of the micelles as well as being able to utilize the freely mobile PRX segments as a ligand installation moiety. In this regard, triblock copolymers that comprise PEG/α-CD PRX as a central block and hydrophobic poly(benzyl methacrylate) chains (PBzMA-b-PRX-b-PBzMA) have been designed to form supramolecular polymeric micelles with an outermost layer of PRX loops. diameter of 100 to 150 nm. 86 These polymeric micelles undergo a morphological change to form a bundle-like aggregate when the pH decreases to 2. A similar morphological change of supramolecular assemblies is also observed in pseudopolyrotaxanes between α-CDs and PEG-b-poly(acrylic acid) (PEG-b-PAA). 87 The α-CDs thread onto PEG segments of PEG-b-PAA in the first stage to form rod-like PRX aggregates, and then evolve into spherical assemblies after 7 days.
Polyrotaxane-based hollow nanoparticles
Hollow nanoparticles have attracted much attention as a new class of colloidal nanoparticles that has potential for application in drug delivery systems. 88 One method for constructing hollow nanoparticles such as polymersomes, is the self-assembly of well-defined diblock copolymers or surfactants through hydrophobic interactions and hydrogen bonding. The self-assembly structure of amphiphilic diblock copolymers can vary from spherical micelles to cylindrical micelle to Page 12 of 40 ChemComm polymersomes, and these superstructures are theoretically governed by a packing parameter of amphiphilic diblock copolymers. 89, 90 Typically, amphiphilic diblock copolymers with short hydrophilic segments (a packing parameter between 1/2 to 1) form polymersomes.
The host-guest inclusion complexation of cyclic molecules has also been employed to construct self-assembled hollow particles. 91 Jiang and co-workers reported on the preparation of supramolecular hollow particles formed from the host-guest inclusion complexation of β-CD-bearing polymers and adamantine-bearing polymers, in which β-CD and adamantine in the side-chain of each polymer form multivalent host-guest complexes. 92 Huang and co-workers successfully prepared various supramolecular particles, including hollow particles, through the self-assembly of diblock copolymers composed of a supramolecular polymer and a traditional hydrophilic polymer. 78 In this study, the supramolecular polymer segments were composed of a host-guest interaction of crown ethers and guest molecules to induce the self-assembly of diblock copolymers in aqueous solution.
Wang and co-workers developed PRX-based hollow nanoparticles composed of Pluronic F127
(PEG-b-PPG-b-PEG) and α-CD via the hydrothermal treatment of the inclusion complex. 93 TEM observations clearly demonstrate the formation of hollow nanoparticles. The diameters and wall thicknesses of the hollow nanoparticles can be varied via the ratio of α-CD to F127.
Another method for constructing hollow nanoparticles is the template method. In this method, the polymers are deposited around template nanoparticles, followed by removal of the template core to obtain hollow nanoparticles. Li and co-workers reported on the preparation of PRX-based hollow nanoparticles using gold nanoparticles as a template. 94 These researchers layered α-CDs on the PEG-modified gold nanoparticles through the formation of an inclusion complex, and then the threaded α-CDs were cross-linked. Finally, the template gold nanoparticles were removed by cyan etching to obtain PRX-based hollow nanoparticles. Similarly, Caruso and co-workers prepared PRX-based degradable hollow nanoparticles on template silica nanoparticles. 95 PEG/α-CD PRX terminated with alkyne stoppers via disulfide linkages were grafted to azide-functionalized silica particles (2.76 µm in diameter) using azide-alkyne click chemistry. Then, the PRXs modified on the surface of the silica particles were cross-linked with a degradable linker (cystamine). Finally, the silica particles were dissolved by hydrofluoric acid (HF) treatment to obtain a robust cross-linked hollow particle. The anticancer drug doxorubicin (DOX) was conjugated to the threaded α-CDs in PRX-based hollow particles. The conjugated DOX was released by the addition of GSH, which degraded the hollow particles via the cleavage of disulfide linkages in the PRXs and cross-linkers.
The researchers also developed a PRX-based hollow particle using the layer-by-layer assembly of PRXs. 96 The PRX hollow particles were prepared by the sequential deposition of positively-charged and negatively-charged PRXs onto silica particles. 96, 97 Then, the template silica particles were dissolved by HF treatment to obtain polyelectrolyte hollow particles. These PRX hollow particles are of interest for a broad range of applications.
Polyelectrolyte complex formation of polyrotaxanes with nucleic acids
In molecular biology and cell biology research, plasmid DNA (pDNA) and small interfering RNA To validate the contribution of the supramolecular dissociation of DMAE-SS-PRXs to gene expression, in vitro luciferase gene expression using DAME-SS-PRX/pDNA complexes has been compared with that using linear PEI/pDNA and non-cleavable DMAE-PRX/pDNA. 106 The gene expression efficiency of the DMAE-SS-PRX/pDNA complex was observed to be independent of the N/P ratio (mixing ratio of amino groups in DMAE-SS-PRX to phosphate groups in pDNA), although that of the PEI/pDNA increased with the N/P ratio. These results suggest that the gene expression of the DMAE-SS-PRX is independent of the amount of free polycations. It is evident that the intracellular cleavage of disulfide linkages in DMAE-SS-PRXs plays a pivotal role in enhancing 
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These cationic PRX-based carrier systems have been utilized in the delivery of siRNA. For example, PEG/α-CD and ionene/α-CD PRXs have been reported to demonstrate the potential ability of cationic PRXs in siRNA delivery. [126] [127] [128] [129] Our group has performed a comprehensive study to verify the supramolecular structure-function relationship of biocleavable DMAE-SS-PRXs in siRNA delivery. 130 The binding ability of DMAE-SS-PRXs to siRNA and the stability of When the terminal cleavable-linkers in PRXs are transformed into acid-degradable ester linkages (DMAE-COO-PRX), the gene silencing activity increases further. 131 In response to the acidic pH in endosomes, the ester linkages of the DMAE-COO-PRXs are hydrolyzed, and an abundance of DMAE-modified CDs is thought to be released from the PRXs. In this situation, the released α-CDs might undergo endosomal membrane destabilization through the removal of phospholipids from the membrane, resulting in the endosomal escape of siRNA and enhanced gene silencing. Indeed, confocal laser scanning microscopic (CLSM) observations have revealed that the colocalization ratio of siRNAs to endosomes decreased for DMAE-COO-PRX compared with that for DMAE-SS-PRX. Thus, the cellular uptake and intracellular trafficking of the PRX/siRNA complexes can be modulated by varying the supramolecular structure and cleavable linkers in PRXs.
Polyelectrolyte complex formation of polyrotaxanes with proteins
Our group has also applied biocleavable DMAE-SS-PRX to protein delivery. 132 The intracellular delivery of proteins is an essential methodology to extend the therapeutic application of protein To investigate the activity of the delivered enzymes in living cells, membrane-permeable TokyoGreen-β-Gal (TG-β-gal) was used as a substrate to monitor the enzymatic activity via the fluorescence intensity. 134 CLSM images of the HeLa cells after incubation with TG-β-gal for 30 min revealed that in contrast to non-cleavable DMAE-PRX/β-gal, the cleavable DMAE-SS-PRX/β-gal exhibits a remarkably bright green fluorescence derived from the enzymatic conversion of TG-β-gal ( Figure 6B ). This result suggests that the enzymatic activity of the delivered β-gal under intracellular environments for cleavable DMAE-SS-PRX is higher than that of non-cleavable DMAE-PRX. To quantify the fluorescence intensity and to compare the kinetics of the intracellular enzymatic reaction, the time-course of the fluorescence intensity change was monitored after the addition of TG-β-gal. In the intracellular environment, the PRX-based enzyme complexes exhibited a higher intracellular fluorescence intensity compared with that of the non-cleavable DMAE-PRX/β-gal complexes ( Figure 6C ). This result suggests that the intracellular dissociation of DMAE-SS-PRXs and the subsequent release of β-gal contribute to enhancing the activity of the delivered enzymes.
Accordingly, the biocleavable DMAE-SS-PRXs provide an attractive technique for delivering various therapeutic bioactive molecules into living cells and enhancing their biological activity through supramolecular dissociation in the intracellular environment.
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Polyrotaxanes as a macromolecular drug
Polyrotaxane-drug conjugates
Polymer-drug conjugates are a class of promising drug delivery candidates for modulating the drug distribution in the body and the therapeutic efficacy of drugs. In particular, drugs are covalently conjugated to the side chain or terminal of hydrophilic polymers, such as poly(2-hydroxypropyl methacrylamide) (PHPMA), poly(styrene-co-malic acid), poly(glutamic acid), and PEG, via cleavable linkers. 134 Biocleavable PRXs have potential as macromolecular drugs that use supramolecular dissociation to release drug-conjugated CDs. In this regard, PRX-drug conjugates comprising theophylline, an asthma drug, and PEG/α-CD PRXs bearing enzymatically-degradable stoppers have been synthesized. 135 Upon the addition of an enzyme (papain), theophylline-immobilized α-CDs were completely released from PRX via hydrolysis of the terminal stoppers. It is suggested that the PRX-drug conjugates that can release drugs via the dissociation of the supramolecular structure could be applied in the delivery of various drugs.
Another type of supramolecular drug conjugates is PRX-drug conjugates coupled with hydrolysable ester linkages. Based on our achievement in biodegradable PRX studies, Yang and coworkers reported on PEG/α-CD PRX-camptothecin and PEG/α-CD PRX-doxorubicin conjugates, in which the anticancer drugs are covalently coupled to α-CD moieties on PRX via ester linkages. 136, 137 The conjugated drugs were observed to be released from PRX under physiological conditions. Additionally, the researchers demonstrated that both PRX-camptothecin and PRX-doxorubicin conjugates exhibit cytotoxic effects against cancer cells in vitro. Jiang and co-workers developed PPG/β-CD PRX-paclitaxel conjugates and investigated their drug distribution in mice and their in vivo antitumor activity. 138 The half-life of PRX-paclitaxel conjugates in mice after intravenous administration was determined to be 5.8 h, which is significantly longer than that of free paclitaxel (18.8 min). Therefore, PRX-drug conjugates are beneficial for prolonging the circulation time and drug distribution. Additionally, the intravenous administration of PRX-paclitaxel
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conjugates to tumor-bearing mice resulted in delayed tumor growth compared with that of free paclitaxel. This result is presumably due to the preferential accumulation of PRX-paclitaxel conjugates in tumor tissues through the EPR effect.
Biocleavable polyrotaxanes as therapeutics for lysosomal storage disorders
As mentioned above, our group has paid special attention to the supramolecular dissociation of PRX in the design of biomaterials. Accompanied by the dissociation of PRX, the abundant threading CDs are released from PRXs. Next, we have attempted to utilize the stimulus-responsive release property of CDs for the treatment of lysosomal diseases, which are a family of intracellular metabolic diseases caused by the defective function of lysosomal proteins. 139 Among various lysosomal diseases, Niemann-Pick type C (NPC) disease is an autosomal recessive lysosomal trafficking disorder, in which the cholesterols are abnormally accumulated in lysosomes. 140, 141 Recently, hydroxypropyl-β-cyclodextrin (HP-β-CD) has received much attention as a potential therapeutics for NPC disease. 142, 143 It has been revealed that the administration of HP-β-CD reduces the cholesterol content in various organs, leading to a remarkable life-span prolongation of mice with a model of NPC disease. However, despite the significant therapeutic effect of HP-β-CD, a high dose is required for NPC disease therapy due to its non-specific inclusion of plasma components and its short blood-circulation time. Additionally, CDs are known to have a toxic effect at high concentration. 144 To address these drawbacks, we focused on biocleavable Pluronic/β-CD PRXs bearing terminal disulfide linkages ( Figure 7A) . 145 Biocleavable PRXs have tremendous advantages that allow them to overcome all of the problems of β-CDs in NPC disease therapy, such as masking the toxic effect of β-CD derivatives, retardation of renal clearance, preferential accumulation in endosomes/lysosomes through endocytosis, and site-specific exposure of the hydrophobic cavity of β-CDs via cleavage of the terminal linker of PRXs in intracellular environments to achieve the therapeutic effect.
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The CLSM observation of the FITC-labeled biocleavable PRXs revealed these supermolecules exhibit negligible interaction with the plasma membrane and mainly accumulate in the late endosomes, whereas HP-β-CDs preferentially accumulate at the periphery of cells ( Figure 7B ).
Additionally, HP-β-CDs removed the cholesterol from the plasma membrane, leading to a disruption of the integrity of the plasma membrane. In contrast, biocleavable PRX causes negligible removal of cholesterols from the plasma membrane because the hydrophobic cavity of β-CDs is occupied by a polymer chain. Accordingly, HP-β-CDs exhibit higher hemolytic activity and cytotoxicity than those of biocleavable PRXs. To validate the cholesterol removal ability of PRXs, the amount of intracellular cholesterol in NPC patient-derived fibroblasts was investigated. Notably, the lysosomal release of threaded β-CDs from biocleavable PRXs by the intracellular cleavage of terminal disulfide
linkages achieved approximately 100-fold higher cholesterol removal ability from NPC disease-derived cells than that of β-CD derivatives ( Figure 7C ). In contrast, non-cleavable PRXs caused a negligible reduction in the cholesterol amount in NPC-disease-derived cells. Consequently, the biocleavable PRXs are considered a noninvasive and effective therapeutic for NPC disease.
Conclusions
In this review, we described the recent progress in using threaded macromolecules, including In this feature article, the recent progress in biomaterial application of threaded macromolecules including polyrotaxanes such as drug delivery and gene delivery are described.
